Literature DB >> 26312770

HMGB1 Turns Renal Tubular Epithelial Cells into Inflammatory Promoters by Interacting with TLR4 During Sepsis.

Shixiang Zheng1, Yangbin Pan1,2, Cairong Wang3, Yipeng Liu4, Ming Shi1, Guohua Ding1.   

Abstract

Our study was undertaken to investigate whether the inflammatory mediator high-mobility group box 1 (HMGB1) can enter the renal tissue and urine and what is the functional change of renal tubular epithelial cells (TECs) interacting with HMGB1 during sepsis. We found that the transcription levels of interleukin 1 (IL-1) and interleukin 6 (IL-6) mRNA in TECs increased significantly during sepsis and these processes can be blocked by splenectomy. We also found out HMGB1 accumulated in the renal tissue and entered urine during sepsis and toll-like receptor 4 (TLR4) was expressed by TECs. In vitro, we demonstrated that HMGB1 induced MAPK and NF-κB activation and G1 cell cycle arrest in TECs. We also found that the mRNA transcription levels of IL-1, IL-6, and tissue inhibitor of metalloproteinases 2 (TIMP2) increased significantly and the IL-1, IL-6, and TIMP2 can be secreted by TECs stimulated by HMGB1. In contrast, LPS RS can block all of the processes above in vitro. In vivo, the increase of the mRNA transcription level of TIMP2 was also observed. These data indicate that HMGB1 accumulates in renal tissue and enters the urine and the interaction between HMGB1 and TLR4 turns TECs into inflammatory promoters during sepsis.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26312770     DOI: 10.1089/jir.2015.0067

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  17 in total

1.  Urinary MCP-1、HMGB1 increased in calcium nephrolithiasis patients and the influence of hypercalciuria on the production of the two cytokines.

Authors:  Yang Wang; Chun Sun; Chengyang Li; Yaoliang Deng; Guohua Zeng; Zhiwei Tao; Xiang Wang; Xiaofeng Guan; Yutong Zhao
Journal:  Urolithiasis       Date:  2016-07-08       Impact factor: 3.436

2.  Suppression of lncRNA GAS6-AS2 alleviates sepsis-related acute kidney injury through regulating the miR-136-5p/OXSR1 axis in vitro and in vivo.

Authors:  Hongrui Cui; Guangwei Ren; Xiuhong Hu; Baozhen Xu; Yuping Li; Zheli Niu; Liqin Mu
Journal:  Ren Fail       Date:  2022-12       Impact factor: 3.222

3.  Sirtuin 6 overexpression relieves sepsis-induced acute kidney injury by promoting autophagy.

Authors:  Yang Zhang; Ling Wang; Lei Meng; Guangke Cao; Yu Wu
Journal:  Cell Cycle       Date:  2019-01-30       Impact factor: 4.534

Review 4.  Damage-Associated Molecular Patterns As Double-Edged Swords in Sepsis.

Authors:  Mian Zhou; Monowar Aziz; Ping Wang
Journal:  Antioxid Redox Signal       Date:  2021-03-30       Impact factor: 8.401

5.  Glutamine ameliorates lipopolysaccharide-induced cardiac dysfunction by regulating the toll-like receptor 4/mitogen-activated protein kinase/nuclear factor-kB signaling pathway.

Authors:  Wen-Bin Zhang; Hai-Yue Zhang; Qian Zhang; Fang-Zhou Jiao; Hong Zhang; Lu-Wen Wang; Zuo-Jiong Gong
Journal:  Exp Ther Med       Date:  2017-10-17       Impact factor: 2.447

6.  Blood purification treatment initiated at the time of sepsis diagnosis effectively attenuates serum HMGB1 upregulation and improves patient prognosis.

Authors:  Shixiang Zheng; Qinyong Weng; Wenwei Wu; Guohua Ding
Journal:  Exp Ther Med       Date:  2017-07-31       Impact factor: 2.447

7.  Assessing the recovery from prerenal and renal acute kidney injury after treatment with single herbal medicine via activity of the biomarkers HMGB1, NGAL and KIM-1 in kidney proximal tubular cells treated by cisplatin with different doses and exposure times.

Authors:  Sung-Man Oh; Gunhyuk Park; Seung Hoon Lee; Chang-Seob Seo; Hyeun-Kyoo Shin; Dal-Seok Oh
Journal:  BMC Complement Altern Med       Date:  2017-12-19       Impact factor: 3.659

8.  Lipopolysaccharide Stimulates Surfactant Protein-A in Human Renal Epithelial HK-2 Cells through Upregulating Toll-like Receptor 4 Dependent MEK1/2-ERK1/2-NF-κB Pathway.

Authors:  Jiao Liu; Guang Li; Wen-Jie Xie; Lu Wang; Rui Zhang; Ke-Sheng Huang; Qing-Shan Zhou; De-Chang Chen
Journal:  Chin Med J (Engl)       Date:  2017-05-20       Impact factor: 2.628

Review 9.  Targeting HMGB1 for the treatment of sepsis and sepsis-induced organ injury.

Authors:  Chao Deng; Lin Zhao; Zhi Yang; Jia-Jia Shang; Chang-Yu Wang; Ming-Zhi Shen; Shuai Jiang; Tian Li; Wen-Cheng Di; Ying Chen; He Li; Ye-Dong Cheng; Yang Yang
Journal:  Acta Pharmacol Sin       Date:  2021-05-26       Impact factor: 6.150

10.  Lipopolysaccharide Mediates the Destruction of Intercellular Tight Junction among Renal Tubular Epithelial Cells via RhoT1/SMAD-4/JAM-3 Pathway.

Authors:  Shixiang Zheng; Zhuoyong Lin; Zhongwei Liu; Yipeng Liu; Wenwei Wu
Journal:  Int J Med Sci       Date:  2018-03-14       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.